OrganiGram Holdings Inc (OGRMF)

NEW YORK, May 6, 2019 /PRNewswire/ --  CannaStocks2019 today announced that its Q1 Investor Conference will be held at the OTC Markets Group offices in New York on May 15 th.

Five top marijuana stocks and four CBD plays in this speculative space.

When it comes to products related to cannabis consumption, a rich universe of options continues to scale up around oils and edibles.

Analyst Owen Bennett also says the market could rise to as high as $130 billion in 10 years.

Valens GroWorks gains traction in rapidly growing space.

As cannabis becomes more and more legal, investors have started to wonder what that means for them.

An early look at the market shows supply is finding it tough to keep up with demand.

As cannabis becomes increasingly legalized in a recreational and medicinal capacity, what actually are the side effects of marijuana? Experts told TheStreet the things you need to know about how the plant affects you.

THC is the psychoactive ingredient in marijuana that produces the feeling of being high. But, THC also has other applications that include health benefits and some side effects.

Echelon initiates coverage on Organigram, a cannabis company.

A total of $1.2 billion in debt via 52 transactions was floated by public and private cannabis companies in the six months ended June 29.

Growth is almost guaranteed in these two areas, says James McDonald of Index Strategy Advisors.

The outperformance of stocks in January has been linked to the sale of assets that have performed poorly and year-end tax selling, but a different market could occur in 2017.